Abstract:Significance: The choroid plexus (ChP) epithelial network displays diverse dynamics, including propagating calcium waves and individuated fluctuations in single cells. These rapid events underscore the possibility that ChP dynamics may reflect behaviorally relevant and clinically important changes in information processing and signaling. Optogenetic and chemogenetic tools provide spatiotemporally precise and sustained approaches for testing such dynamics in vivo. Here, we describe the feasibility of a novel combined opto- and chemogenetic tool, BioLuminescent-OptoGenetics (BL-OG), for the ChP in vivo. In the "LuMinOpsin" (LMO) BL-OG strategy, a luciferase is tethered to an adjacent optogenetic element. This molecule allows chemogenetic activation when the opsin is driven by light produced through luciferase binding a small molecule (luciferin) or by conventional optogenetic light sources and BL-OG report of activation through light production. Aim: To test the viability of BL-OG/LMO for ChP control. Approach: Using transgenic and Cre-directed targeting to the ChP, we expressed LMO3 (a Gaussia luciferase-VChR1 fusion), a highly effective construct in neural systems. In mice expressing LMO3 in ChP, we directly imaged BL light production following multiple routes of coelenterazine (CTZ: luciferin) administration using an implanted cannula system. We also used home-cage videography with Deep LabCut analysis to test for any impact of repeated CTZ administration on basic health and behavioral indices. Results: Multiple routes of CTZ administration drove BL photon production, including intracerebroventricular, intravenous, and intraperitoneal injection. Intravenous administration resulted in fast "flash" kinetics that diminished in seconds to minutes, and intraperitoneal administration resulted in slow rising activity that sustained hours. Mice showed no consistent impact of 1 week of intraperitoneal CTZ administration on weight, drinking, motor behavior, or sleep/wake cycles. Conclusions: BL-OG/LMO provides unique advantages for testing the role of ChP dynamics in biological processes.

A new light on PLCβ!

Optogenetic Engineering to Probe the Molecular Choreography of STIM1-mediated Cell Signaling

Optogenetic control of cell function using engineered photoreceptors

Efficient opto- and chemogenetic control in a single molecule driven by FRET-modified bioluminescence

High fidelity optogenetic control of individual prefrontal cortical pyramidal neurons in vivo

A bistable inhibitory optoGPCR for multiplexed optogenetic control of neural circuits

BioLuminescent OptoGenetics in the choroid plexus: integrated opto- and chemogenetic control in vivo

Wireless Optogenetics Injectable , Cellular-Scale Optoelectronics with Applications for

In Vivo Expression of a Light-Activatable Potassium Channel Using Unnatural Amino Acids

An optogenetic method for the controlled release of single molecules

Optogenetic control of genetically-targeted pyramidal neuron activity in prefrontal cortex

The crystal and cryo-EM structures of PLCγ2 reveal dynamic interdomain recognitions in autoinhibition

Efficient synthesis of phycocyanobilin in mammalian cells for optogenetic control of cell signaling

Light control of G protein signaling pathways by a novel photopigment

Recent Advances in Cellular Optogenetics for Photomedicine

STX-bpc: “brightening” the Path to Neuronal Inhibition

A photoswitchable GPCR-based opsin for presynaptic inhibition

Guiding lights: recent developments in optogenetic control of biochemical signals

Using split protein reassembly strategy to optically control PLD enzymatic activity

Dual-controlled optogenetic system for the rapid down-regulation of protein levels in mammalian cells

Optogenetic Application to Investigating Cell Behavior and Neurological Disease